142P Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Isla, D., Arriola, E., Garcia Campelo, M.R., Martí, C., Diz Tain, P., Moreno Vega, A.L., Piqueras, M.L-B., León, L., Gutierrez Calderon, V., Oramas Rodriguez, J.M., Majem, M., Sanchez-Hernandez, A., Aguado de la Rosa, C., Alvarez Cabellos, R., Marti-Ciriquian, J.L., Moreno Paul, A., Gonzalez Cordero, M., Callejo Mellén, Á., Baez, L., Zugazagoitia, J.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
57TiP SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial
Balmana, J., Pascual, T., Llop-Guevara, A., Tolosa, P., Blancas López-Barajas, I., Perez Lopez, M.E., Adamo, B., Teruel-Garcia, I., Ponce, J., González-Cordero, M., Viñas Villaro, G., Lema Roso, L., Salvador Bofill, F.J., M. Martinez, M.T., Guerrero, A.N.E., Prat, A., Serra Elizalde, V.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article